Drug Testing Laws in New Jersey

State law (New Jersey): Employers do have the right to maintain a drug- and alcohol-free work environment. They may test randomly for impairment, and may test an employee who appears intoxicated at work or who was involved in a workplace accident Source 2State agencyWorkplace & DUI Laws — adult personal use cannabis — checked 18 Aug 2026.

State law (New Jersey): What they may not do is treat general cannabis use as the determining factor in hiring or firing someone Source 2State agencyWorkplace & DUI Laws — adult personal use cannabis — checked 18 Aug 2026.

Employer policy: Those two statements sit together more comfortably than they first appear. New Jersey has not restricted testing. It has restricted what a test result can carry on its own — which shifts the burden onto documented observation at work.

State law (New Jersey): General cannabis use cannot be a determining factor in a hiring decision Source 2State agencyWorkplace & DUI Laws — adult personal use cannabis — checked 18 Aug 2026.

Employer policy: So the useful question for a New Jersey applicant looking at a positive cannabis screen is not whether the test was accurate, but what the employer proposes to rest a decision on — because the Commission's position is that the metabolite finding alone does not carry it Source 1State agencyGuidance on workplace impairment (interim, pending WIRE certification standards) — checked 18 Aug 2026.

State law (New Jersey): Random testing for impairment is permitted, as is testing an employee who appears intoxicated or who was involved in a workplace accident Source 2State agencyWorkplace & DUI Laws — adult personal use cannabis — checked 18 Aug 2026.

The constraint is not on the testing. It is on the inference: whatever the trigger, a metabolite result standing alone is not a sufficient basis for adverse action Source 1State agencyGuidance on workplace impairment (interim, pending WIRE certification standards) — checked 18 Aug 2026.

State law (New Jersey): The operative rule, in the Commission's own framing: a scientifically reliable objective testing method indicating the presence of cannabinoid metabolites in an employee's bodily fluid is alone insufficient to support an adverse employment action. Combined with evidence-based documentation of physical signs or other evidence of impairment during the employee's prescribed work hours, it may be sufficient Source 1State agencyGuidance on workplace impairment (interim, pending WIRE certification standards) — checked 18 Aug 2026.

State law (New Jersey): The Commission sets out how that documentation should be produced: a Reasonable Suspicion Observation Report completed by a manager or supervisor together with a designated trained staff member, recording the behavioural and physical indicators actually observed during work hours. It publishes a sample form for the purpose Source 1State agencyGuidance on workplace impairment (interim, pending WIRE certification standards) — checked 18 Aug 2026.

Employer policy: If you run testing in New Jersey, this is the practical takeaway: the observation report is not paperwork, it is the part that makes the decision defensible. A file containing only a laboratory result is, on the Commission's own guidance, an incomplete basis Source 1State agencyGuidance on workplace impairment (interim, pending WIRE certification standards) — checked 18 Aug 2026.

State law (New Jersey): Medical cannabis and employment run on a separate track, governed by the Jake Honig Act at N.J.S.A. C.24:6I-6.1, alongside the New Jersey Supreme Court's decision in Wild v. Carriage Funeral Holdings Source 2State agencyWorkplace & DUI Laws — adult personal use cannabis — checked 18 Aug 2026.

We are naming that track rather than summarising it: we have read the Commission's workplace pages, not the Act or the judgment. If you are a registered patient, the protections available to you may be different from the adult-use position described above, and this page does not attempt to state them.

State law (New Jersey): The statute authorises the Commission to set standards for a Workplace Impairment Recognition Expert — a WIRE, trained in detecting and identifying an employee's use of, or impairment from, a cannabis item or other intoxicating substance — at N.J.S.A. 24:6I-52a(2)(a) Source 1State agencyGuidance on workplace impairment (interim, pending WIRE certification standards) — checked 18 Aug 2026.

Read the status carefully, because it is the moving part on this page. The guidance was issued on 9 September 2022 and states expressly that it serves until the Commission formulates and approves WIRE certification standards. No certification was available at issuance Source 1State agencyGuidance on workplace impairment (interim, pending WIRE certification standards) — checked 18 Aug 2026. If those standards have since been adopted, this guidance may have been superseded — check the verification date at the top of this page against today.

Federal (DOT): No state cannabis protection reaches a DOT-regulated test. The federal panel includes marijuana, the cutoffs are federal, and a verified positive carries federal consequences regardless of New Jersey's position on metabolites.

A gap we are declaring: the Commission's workplace page does not address federal contractor exceptions or federally regulated roles Source 2State agencyWorkplace & DUI Laws — adult personal use cannabis — checked 18 Aug 2026, and we have not found a state source that does. Nothing on this page should be read as describing how New Jersey law interacts with a federal contract obligation.